Neurogene Inc. (NGNE) Stock Grade

About Neurogene Inc.'s fundamentals

Neurogene Inc. is a biotechnology company with a market capitalization of $436.1 million that is currently not profitable, reporting a net loss in its latest annual statement with a 0.0% net margin. The company experienced a complete decline in revenue year-over-year (-100.0%), indicating no ongoing revenue generation in its most recent reporting period. The company does not pay a dividend, and standard profitability metrics like P/E ratio and return on equity are not applicable due to the loss-making status.